statin

Groundbreaking research reveals patients with chronic lymphocytic leukemia or small lymphocytic lymphoma taking statins showed 61% lower cancer mortality and 38% reduced all-cause mortality when receiving targeted therapies like ibrutinib.

Researchers from Imperial College London and Lund University found that early combination therapy with statins and ezetimibe significantly reduces the risk of subsequent heart attacks and death in cardiac patients.

Elevated lipoprotein(a) affects approximately 20% of adults and is primarily genetically determined, serving as a significant risk marker for atherosclerotic cardiovascular disease, aortic stenosis, heart failure, and atrial fibrillation.

Merck will present late-breaking data from the Phase 3 ZENITH trial evaluating WINREVAIR (sotatercept-csrk) in high-risk pulmonary arterial hypertension patients, which was concluded early due to overwhelming efficacy.

Eli Lilly's Mounjaro (tirzepatide) has shown superior efficacy in reducing HbA1c levels and body weight compared to Novo Nordisk's Ozempic in clinical trials, offering new hope for the 35 million Americans with type 2 diabetes.